Updated: Jan 2024
International patients can receive CAR-T cell therapy in several countries, including the United States, Canada, Germany, France, Spain, the United Kingdom, Italy, Israel, Australia, China, and Singapore.
These countries have established treatment centers and offer FDA-approved CAR-T therapy for various conditions, such as B cell acute lymphoblastic leukemia, certain B cell lymphoma subtypes, mantle cell lymphoma, and multiple myeloma.
While the availability of CAR-T cell therapy is expanding, some countries are still in the process of adopting and funding these treatments, and access may vary based on individual needs and circumstances.
Sources:
- Susupport- Pioneering biopharma
- Frontiers in Medicine
- NIH National Library of Medicine
- Pharmaceutical Technology
- Frontiers in Medicine
- Springer Link
Links:
CAR-T cell therapy in Israel
